array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Natus Medical Incorporated" ["slug"]=> string(35) "05e48-us-natus-medical-incorporated" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a" ["description"]=> string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status." ["address_street"]=> string(29) "6701 Koll Center Pkwy Ste 120" ["address_place"]=> string(10) "Pleasanton" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1987-02-13" ["website_domain"]=> string(9) "natus.com" ["website_url"]=> string(17) "https://natus.com" ["industry_codes"]=> array(1) { [0]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(1480) ["article_count"]=> int(148) } ["articles"]=> array(2) { [0]=> array(7) { ["title_en"]=> string(44) "Natus Medical Announces Executive Transition" ["snippet_en"]=> string(150) "Thomas J. Sullivan Appointed President & Chief Executive Officer No Change To 4th Quarter Guidance PLEASANTON, Calif., Dec. 17, 2021 (GLOBE..." ["url"]=> string(112) "https://globenewswire.com/news-release/2021/12/17/2354695/0/en/natus-medical-announces-executive-transition.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2f58f4e1-c2b3-4e90-a06e-71c9f8bd4a4d" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2021-12-17" ["categories"]=> array(3) { [0]=> string(12) "Board Change" [1]=> string(11) "Name Change" [2]=> string(10) "Executives" } } [1]=> array(7) { ["title_en"]=> string(65) "Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS”" ["snippet_en"]=> string(161) "PLEASANTON, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical." ["url"]=> string(131) "https://www.globenewswire.com/news-release/2019/07/25/1888240/0/en/Natus-Medical-Announces-NASDAQ-Ticker-Symbol-Change-to-NTUS.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/904789ad-f6f4-4670-9f56-46e19719cfec" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2019-07-25" ["categories"]=> array(1) { [0]=> string(11) "Name Change" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(23) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(12) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(11) } [3]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [4]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(7) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(5) } [6]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(4) } [9]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(3) } [10]=> array(2) { ["name"]=> string(5) "SPACs" ["count"]=> int(3) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(10) "Downsizing" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(11) "Name Change" ["count"]=> int(2) } [21]=> array(2) { ["name"]=> string(22) "Shareholder Reputation" ["count"]=> int(2) } [22]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(2) } [23]=> array(2) { ["name"]=> string(5) "Fraud" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(10) "Complaints" ["count"]=> int(1) } } } 05e48-us-natus-medical-incorporated